MB

Mahesh Badlani

Active Director Director DIN 00070393
DIN 00070393 First appointment Mar 1994 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 3 historical roles
Total affiliations 8 Since Mar 1994
Shareholding value •••• Premium profile

About Mahesh Badlani

Data last updated:

Mahesh Badlani has 32 years in corporate governance. Holds Director role. Currently with 5 companies, including Pure Pharma Limited and Prochem Laboratories Pvt. Ltd. Formerly with 3 companies, such as S.N.Hingorani Consultants And Investments Pvt Ltd and Cecil Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹202 Cr; the largest is Prochem Pharmaceuticals Private Limited at ₹195 Cr (FY 2025).

DIN 00070393
Primary Designation Director
First Appointment 02 Mar 1994
Oldest Company Age 55 yrs
Largest company Prochem Pharmaceuticals Private Limited · ₹195 Cr (FY 2025)
Combined revenue ₹202 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Sep 20162016₹195 Cr (FY 2025)Active
Pure Pharma Limited U24232MP1980PLC001647
Director01 Apr 20011980₹5.01 Cr (FY 2024)Active
Promed Laboratories Private Limited U85195MP1971PTC001100
Director02 Mar 19941971₹1.67 Cr (FY 2025)Active
Prochem Laboratories Pvt. Ltd U24232MP1989PTC005391
Director15 Mar 20191989–Active
Jpbee Investments Pvt Ltd N U67120MP1994PTC008623
Director15 Mar 20191994–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Jan 20011995–Strike Off
Director08 Nov 20051996–Active
Director28 Nov 20112011₹10,668 (FY 2016)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Pure Pharma Limited
Prochem Laboratories Pvt. Ltd
Prochem Pharmaceuticals Private Limited
Jpbee Investments Pvt Ltd N
Premium access

Shareholding and investment profile for Mahesh Badlani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahesh Badlani

Mahesh Badlani has 32 years in corporate governance. Holds Director role. Currently with 5 companies, including Pure Pharma Limited and Prochem Laboratories Pvt. Ltd. Formerly with 3 companies, such as S.N.Hingorani Consultants And Investments Pvt Ltd and Cecil Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹202 Cr; the largest is Prochem Pharmaceuticals Private Limited at ₹195 Cr (FY 2025).

Mahesh Badlani is associated with 5 companies as Director, including Prochem Pharmaceuticals Private Limited (₹195 Cr), Pure Pharma Limited (₹5.01 Cr), Promed Laboratories Private Limited (₹1.67 Cr).

Mahesh Badlani has expertise in General Business.

Mahesh Badlani has 32 years in corporate governance.

By reported revenue, the largest current company of Mahesh Badlani is Prochem Pharmaceuticals Private Limited, with revenue of ₹195 Cr (FY 2025).

The 3 current companies of Mahesh Badlani that report revenue have a combined latest revenue of ₹202 Cr.

Mahesh Badlani currently holds positions at 5 companies: Prochem Pharmaceuticals Private Limited (₹195 Cr), Pure Pharma Limited (₹5.01 Cr), Promed Laboratories Private Limited (₹1.67 Cr), Prochem Laboratories Pvt. Ltd, Jpbee Investments Pvt Ltd N.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available